MRPL48 is a novel prognostic and predictive biomarker of hepatocellular carcinoma

被引：0
|
作者：
Yu-Xiang Lin
Jun-Yong Pan
Wen-Du Feng
Tian-Cong Huang
Cheng-Zong Li
机构：
[1] The Second Affiliated Hospital of Fujian Medical University (Donghai District),Department of Hepatobiliary and Pancreatic Surgery
[2] The Second Affiliated Hospital of Fujian Medical University,Central Supply Service Department
来源：
European Journal of Medical Research | / 28卷
关键词：
Hepatocellular carcinoma; MRPL48; Prognostic value; Biomarker; Biological functions;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] MRPL48 is a novel prognostic and predictive biomarker of hepatocellular carcinoma
    Lin, Yu-Xiang
    Pan, Jun-Yong
    Feng, Wen-Du
    Huang, Tian-Cong
    Li, Cheng-Zong
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [2] Identification of CELSR2 as a novel prognostic biomarker for hepatocellular carcinoma
    Mingxing Xu
    Shu Zhu
    Ruiyun Xu
    Nan Lin
    BMC Cancer, 20
  • [3] Serum Amyloid A is a Novel Prognostic Biomarker in Hepatocellular Carcinoma
    Ni, Xiao-Chun
    Yi, Yong
    Fu, Yi-Peng
    He, Hong-Wei
    Cai, Xiao-Yan
    Wang, Jia-Xing
    Zhou, Jian
    Fan, Jia
    Qiu, Shuang-Jian
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (24) : 10713 - 10718
  • [4] Kindlin-2: A novel prognostic biomarker for patients with hepatocellular carcinoma
    Ge, Yong-Sheng
    Liu, Dong
    Jia, Wei-Dong
    Li, Jian-Sheng
    Ma, Jin-Liang
    Yu, Ji-Hai
    Xu, Ge-Liang
    PATHOLOGY RESEARCH AND PRACTICE, 2015, 211 (03) : 198 - 202
  • [5] Identification of CELSR2 as a novel prognostic biomarker for hepatocellular carcinoma
    Xu, Mingxing
    Zhu, Shu
    Xu, Ruiyun
    Lin, Nan
    BMC CANCER, 2020, 20 (01)
  • [6] A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma
    Wang, Zhihao
    Embaye, Kidane Siele
    Yang, Qing
    Qin, Lingzhi
    Zhang, Chao
    Liu, Liwei
    Zhan, Xiaoqian
    Zhang, Fengdi
    Wang, Xi
    Qin, Shenghui
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 119 - 132
  • [7] Serum Endocan as a Novel Prognostic Biomarker in Patients with Hepatocellular Carcinoma
    Ozaki, Kazuaki
    Toshikuni, Nobuyuki
    George, Joseph
    Minato, Takahiro
    Matsue, Yasuhiro
    Arisawa, Tomiyasu
    Tsutsumi, Mikihiro
    JOURNAL OF CANCER, 2014, 5 (03): : 221 - 230
  • [8] MRGBP is a potential novel prognostic biomarker and is correlated with immune infiltrates in hepatocellular carcinoma
    Huang, Juanjun
    Chen, Xiaoli
    Zhu, Wei
    MEDICINE, 2021, 100 (12) : E25234
  • [9] TPX2 as a novel prognostic biomarker for hepatocellular carcinoma
    Liu, Qingquan
    Tu, Kangsheng
    Zhang, Hongyong
    Zheng, Xin
    Yao, Yingmin
    Liu, Qingguang
    HEPATOLOGY RESEARCH, 2015, 45 (08) : 906 - 918
  • [10] Intelectin-1 is a novel prognostic biomarker for hepatocellular carcinoma
    Li, Jiang
    Tao, Hai-Su
    Yuan, Tong
    Huang, Zhi-Yong
    Zhang, Er-Lei
    MEDICINE, 2023, 102 (48) : E36474
12345